Immune-related Adverse Events after 2 Years in Patients with Advanced Non-Small-cell Lung Cancer Receiving Extended Immune Checkpoint Inhibitor Therapy.
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined